We know how ADXS has interacted with FDA on previous occasions. With each trial it seems more like the company does not have the expertise to design or conduct trials. Add to it the cash problem. Soon another round of begging via capital raise that will probably be the final nail in the coffin.
Going to 2s any day. If so would make a good day trade depending on volume.
"The market cap dived below 25M for the first time in past few months. Not a good sign. I am really puzzled about these three things:" ........ The answer to your 3 questions is very obvious. I have posted many times the ADXS "LM Technology" is a failed technology that is now probably obsolete. I posted that AXAL would not obtain either FDA or EU approval & that any other ADXS products that were LM Technology based would fail. That is why Amgen dumped NEO & why con man Ken Berlin failed to find any upfront cash partner for the overhyped HOT or AXAL. The reasons the market cap collapsed below 25M is the market & all BP know that the ADXS LM Technology is a failure & Ken Berlin in nothing but a vermin con man never to be trusted & believed.
News 
Market Data 
Discover 
